Short answer

No STI test is perfect, and wrong results come in both directions with different causes: false negatives mostly from testing inside window periods, sampling the wrong site, or poor collection; false positives mostly from screening low-prevalence populations with imperfect tests (herpes blood tests above all).

Sensitivity and specificity numbers make sense only combined with personal pre-test probability. And confirmation plus dated retesting resolve both directions.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Sensitivity vs specificity, plainly. The two accuracies

Sensitivity: among infected people, how many test positive (misses equal false negatives. The window-period and wrong-site problem).

Specificity: among uninfected people, how many test negative (false alarms equal false positives. The low-prevalence screening problem).

NAAT tests score high on both (excellent screening and diagnostic performance).

Antibody screens trade some specificity for sensitivity (catching more true cases at the cost of more false alarms. Hence mandatory confirmation steps).

Neither number alone predicts what your result means; prevalence completes the equation.

Why prevalence matters. The math of screening

In low-prevalence groups, even 99%-specific tests yield mostly-false positives among the few positives: testing 1,000 low-risk people produces ~10 false alarms swamping the rare true case.

This Bayes-theorem reality is the technical reason behind “don’t routinely screen low-risk people for herpes with blood tests” and behind every confirmatory algorithm in STI medicine.

Positive predictive value, the chance a given positive is true, depends on pre-test probability (your history) more than on test quality. Same assay, different patient, different meaning.

Each direction in depth: False-Positive STI Tests and False-Negative STI Tests.

Preventing wrong results. Four disciplines

  • Test after windows close (exposure-dated scheduling. The single highest-yield accuracy step).
  • Sample every exposed site (genital plus throat/rectal swabs plus blood work by history. Undisclosed sites go untested).
  • Follow self-test instructions exactly (timing, sample volume, reading windows. Home-technique discipline matching clinic protocol).
  • Disclose exposures fully so clinicians pick correct tests (right assay for the right organism at the right site at the right time. Accuracy is a system, not a kit).

Resolving surprises. Direction-specific protocols

  • Unexpected positive → confirmatory testing before life decisions (alternate assays, tiebreakers, differentiation cascades. Disclosure and treatment follow confirmation, never precede it).
  • Unexpected negative with symptoms → re-evaluation rather than identical repetition (uncovered organisms, wrong sites, non-STI causes. New workups, not reruns).
  • Discordant results → clinician-led tiebreakers (different test types, repeat intervals, exposure-history reconciliation).

Surprises are waypoints requiring protocols, not verdicts requiring reactions.

When to seek care

To confirm any surprising result, for symptoms despite negatives, and for retesting schedules after early post-exposure tests.